A study of CSL346 in Type 2 diabetes patients.
Phase of Trial: Phase I
Latest Information Update: 10 Feb 2017
At a glance
- Drugs CSL 346 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 10 Feb 2017 According to a CSL media release, this trial is expected to initiate in 2017.
- 07 Dec 2016 New trial record